Kessler R C, Nelson C B, McGonagle K A, Liu J, Swartz M, Blazer D G
Institute for Social Research, University of Michigan, Ann Arbor 48106-1248, USA.
Br J Psychiatry Suppl. 1996 Jun(30):17-30.
General population data are presented on the prevalence and correlates of comorbidity between DSM-III-R major depressive disorder (MDD) and other DSM-III-R disorders. The data come from the US National Comorbidity Survey, a large general population survey of persons aged 15-54 years in the non-institutionalised civilian population. Diagnoses are based on a modified version of the Composite International Diagnostic Interview (CIDI). The analysis shows that most cases of lifetime MDD are secondary. In the sense that they occur in people with a prior history of another DSM-III-R disorder. Anxiety disorders are the most common primary disorders. The time-lagged effects of most primary disorders on the risk of subsequent MDD continue for many years without change in magnitude. Secondary MDD is, in general, more persistent and severe than pure or primary MDD. This has special public health significance because lifetime prevalence of secondary MDD has increased in recent cohorts, while the prevalence of pure and primary depression has remained unchanged.
呈现了普通人群中《精神疾病诊断与统计手册第三版修订本》(DSM-III-R)重度抑郁症(MDD)与其他DSM-III-R疾病共病的患病率及相关因素的数据。这些数据来自美国国家共病调查,这是一项针对15至54岁非机构化平民人口的大型普通人群调查。诊断基于复合国际诊断访谈(CIDI)的修订版。分析表明,大多数终生MDD病例是继发性的。也就是说,它们发生在有其他DSM-III-R疾病既往史的人群中。焦虑症是最常见的原发性疾病。大多数原发性疾病对后续MDD风险的滞后效应会持续多年,且强度不变。一般来说,继发性MDD比单纯性或原发性MDD更持久、更严重。这具有特殊的公共卫生意义,因为在最近几代人群中,继发性MDD的终生患病率有所上升,而单纯性和原发性抑郁症的患病率保持不变。